194 related articles for article (PubMed ID: 32151873)
1. Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities.
Sasahara GL; Gouveia Júnior FS; Rodrigues RO; Zampieri DS; Fonseca SGDC; Gonçalves RCR; Athaydes BR; Kitagawa RR; Santos FA; Sousa EHS; Nagao-Dias AT; Lopes LGF
J Inorg Biochem; 2020 May; 206():111048. PubMed ID: 32151873
[TBL] [Abstract][Full Text] [Related]
2. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
3. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
6. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion.
Xie L; Wang L; Guan R; Ji L; Chao H
J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) Polypyridyl Complexes and Metronidazole Derivatives: A Powerful Combination in the Design of Photoresponsive Antibacterial Agents Effective under Hypoxic Conditions.
Giacomazzo GE; Conti L; Fagorzi C; Pagliai M; Andreini C; Guerri A; Perito B; Mengoni A; Valtancoli B; Giorgi C
Inorg Chem; 2023 May; 62(20):7716-7727. PubMed ID: 37163381
[TBL] [Abstract][Full Text] [Related]
8. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
[TBL] [Abstract][Full Text] [Related]
9. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity.
Mallepally RR; Chintakuntla N; Putta VR; K N; Vuradi RK; P M; S SS; Chitumalla RK; Jang J; Penumaka N; Sirasani S
J Fluoresc; 2017 Jul; 27(4):1513-1530. PubMed ID: 28432633
[TBL] [Abstract][Full Text] [Related]
11. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
[TBL] [Abstract][Full Text] [Related]
12. Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and in vitro anticancer activity.
Sathiya Kamatchi T; Chitrapriya N; Kim SK; Fronczek FR; Natarajan K
Eur J Med Chem; 2013 Jan; 59():253-64. PubMed ID: 23234855
[TBL] [Abstract][Full Text] [Related]
13. Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines.
Tabrizi L; Olasunkanmi LO; Fadare OA
Dalton Trans; 2019 Jan; 48(2):728-740. PubMed ID: 30560261
[TBL] [Abstract][Full Text] [Related]
14. Near-IR light-induced photorelease of nitric oxide (NO) on ruthenium nitrosyl complexes: formation, reactivity, and biological effects.
Giri B; Saini T; Kumbhakar S; Selvan K K; Muley A; Misra A; Maji S
Dalton Trans; 2020 Aug; 49(31):10772-10785. PubMed ID: 32706352
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
[TBL] [Abstract][Full Text] [Related]
16. Nitroimidazole-Based Ruthenium(II) Complexes: Playing with Structural Parameters to Design Photostable and Light-Responsive Antibacterial Agents.
Giacomazzo GE; Conti L; Guerri A; Pagliai M; Fagorzi C; Sfragano PS; Palchetti I; Pietraperzia G; Mengoni A; Valtancoli B; Giorgi C
Inorg Chem; 2022 May; 61(18):6689-6694. PubMed ID: 34793162
[TBL] [Abstract][Full Text] [Related]
17. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
19. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
20. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
